VEGFA and polycystic ovary syndrome: With respect to angiogenic growth factors, the pre-treatment plasma VEGF difference was not significant between PCOS and control (Figure 3A), but TVOR plasma has higher VEGF (p < 0.05) in PCOS (Figure 3B).